Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of megestrol acetate in patients receiving adjuvant chemotherapy for gastric cancer
KCT0008479Phase 2Not yet recruiting
- Sponsor
- Korea National Enterprise for Clinical Trials
- Start
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of megestrol in gastric cancer (GC), sponsored by Korea National Enterprise for Clinical Trials. Planned start Nov 2022; status: not yet recruiting.
02
Drugs
megestrol
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on KCT0008479.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0008479.